home / stock / nvs / nvs articles

NVS Articles, Novartis AG - From 06/21/24

Stock Information
Company Name: Novartis AG
Stock Symbol: NVS
Market: NYSE
Menu
NVS NVS Quote NVS Short NVS News NVS Articles NVS Message Board
Get NVS Alerts

News, Short Squeeze, Breakout and More Instantly...
Nestle Carefully Targets Weight-Loss Drug Users with New Food Line | Benzinga

Last month, Nestlé SA (OTC:NSRGF) (OTC:NSRGY) unveiled Vital Pursuit, a new line of foods designed to complement GLP-1 weight loss ...
German Drug Developer Evotec Seeks Adviser Input As Takeover Concerns Mount | Benzinga

German drug developer Evotec SE (NASDAQ:EVO) is reportedly consulting defense advisers following a significant drop in share price, raising concern...

What's Going On With Neurological Disease Focused Trevena On Thursday? | Benzinga

Shares of Trevena Inc (NASDAQ:TRVN) are trading lower on Thursday, with a session volume of 23.65 million, as per data from Benzinga Pro. The compa...

Italy Probes European Pharma Giants Novartis, Roche Over Eye Drug Competition Allegations | Benzinga

Italy’s antitrust regulator has initiated an investigation into several pharmaceutical giants, including Novartis AG (NYSE:NVS) and Roche Hol...
Novartis Sues to Block Maryland's New Drug Discount Law | Benzinga

Novartis AG (NYSE:NVS) has reportedly filed a lawsuit to block a Maryland law requiring drugmakers to offer discounts on drugs dispensed by third-p...

Novartis' Oral Drug For Chronic Skin Disease Candidate Shows Efficacy, Long-term Safety | Benzinga

On Friday, Novartis AG (NYSE:NVS) released new data that confirm the long-term efficacy and safety of remibrutinib, a highly selective Bruton'...

After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February | Benzinga

U.S. drug wholesaler Cencora Inc (NYSE:COR), formerly AmerisourceBergen, is notifying affected individuals about their personal...
Roche Cancer Drug Gets Breakthrough Therapy Designation | Benzinga

Roche (OTC: RHHBY) obtained a Breakthrough Therapy Designation for its investigational oral therapy inavolisib for treating adult breast cancer pat...

Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game | Benzinga

On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a...

MacroGenics Gets Downgraded Following Disappointing Prostate Cancer Trial Results: 'We Were Surprised By Reported Deaths' | Benzinga

MacroGenics Inc (NASDAQ:MGNX) released interim data from the TAMARACK Phase 2 study of vobramitamab duocarmazine (vobra duo). TAMARA...
Previous 10 Next 10